Karolina Pytka

Loop profile Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 30

Top Venues

International journal of molecular sciences

Pharmaceuticals (Basel, Switzerland)

Medicinal research reviews

Phytotherapy research : PTR

Uniwersytet Jagiellonski Collegium Medicum

Uniwersytet Jagiellonski Collegium Medicum (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Uniwersytet Jagiellonski Collegium Medicum Oct 01 2014

Poland

Assistant Professor :: Pharmacodynamics

Strathclyde Institute of Pharmacy and Biomedical Sciences Feb 01 2018 - Feb 01 2019

United Kingdom

Visiting Researcher :: Neuroscience

Tierärztliche Hochschule Hannover

Germany

Visiting Researcher :: Deprtment of Pharmacology

Uniwersytet Jagiellonski Collegium Medicum Dec 01 2010 - Sep 30 2014

Poland

Instructor :: Pharmacodynamics

Education History

Uniwersytet Jagiellonski Collegium Medicum

Poland

PHD :: Department of Pharmacodynamics

Publications

Paulina Dudzik, Klaudia Lustyk, Karolina Pytka
Beyond dopamine: Novel strategies for schizophrenia treatment. Medicinal research reviews (2024)
Paulina Dudzik, Klaudia Lustyk, Karolina Pytka
Beyond dopamine: Novel strategies for schizophrenia treatment. Medicinal research reviews 44 (5) (2024)
Katarzyna Socała, Elżbieta Żmudzka, Klaudia Lustyk, Mirosław Zagaja, Virginia Brighenti, Anna Maria Costa, Marta Andres-Mach, Karolina Pytka, Ilaria Martinelli, Jessica Mandrioli, Federica Pellati, Giuseppe Biagini, Piotr Wlaź
Therapeutic potential of stilbenes in neuropsychiatric and neurological disorders: A comprehensive review of preclinical and clinical evidence. Phytotherapy research : PTR 38 (3) (2024)
Katarzyna Socała, Elżbieta Żmudzka, Klaudia Lustyk, Mirosław Zagaja, Virginia Brighenti, Anna Maria Costa, Marta Andres-Mach, Karolina Pytka, Ilaria Martinelli, Jessica Mandrioli, Federica Pellati, Giuseppe Biagini, Piotr Wlaź
Therapeutic potential of stilbenes in neuropsychiatric and neurological disorders: A comprehensive review of preclinical and clinical evidence. Phytotherapy research : PTR 38 (3) (2024)
Katarzyna Socała, Elżbieta Żmudzka, Klaudia Lustyk, Mirosław Zagaja, Virginia Brighenti, Anna Maria Costa, Marta Andres-Mach, Karolina Pytka, Ilaria Martinelli, Jessica Mandrioli, Federica Pellati, Giuseppe Biagini, Piotr Wlaź
Therapeutic potential of stilbenes in neuropsychiatric and neurological disorders: A comprehensive review of preclinical and clinical evidence. Phytotherapy research : PTR (2024)
Paulina Dudzik, Klaudia Lustyk, Karolina Pytka
Beyond dopamine: Novel strategies for schizophrenia treatment. Medicinal research reviews 44 (5) (2024)
Elżbieta Żmudzka, Klaudia Lustyk, Kinga Sałaciak, Agata Siwek, Jolanta Jaśkowska, Marcin Kołaczkowski, Jacek Sapa, Karolina Pytka
Potential Anti-Amnesic Activity of a Novel Multimodal Derivative of Salicylamide, JJGW08, in Mice. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Anna Janus, Klaudia Lustyk, Karolina Pytka
MK-801 and cognitive functions: Investigating the behavioral effects of a non-competitive NMDA receptor antagonist. Psychopharmacology (2023)
Monika Marcinkowska, Barbara Mordyl, Agata Siwek, Monika Głuch-Lutwin, Tadeusz Karcz, Alicja Gawalska, Michał Sapa, Adam Bucki, Katarzyna Szafrańska, Bartosz Pomierny, Karolina Pytka, Magdalena Kotańska, Kamil Mika, Marcin Kolaczkowski
Dual Molecules Targeting 5-HT 6 and GABA-A Receptors as a New Approach to Combat Depression Associated with Neuroinflammation. ACS chemical neuroscience (2023)
Elżbieta Żmudzka, Klaudia Lustyk, Kinga Sałaciak, Agata Siwek, Jolanta Jaśkowska, Marcin Kołaczkowski, Jacek Sapa, Karolina Pytka
Potential Anti-Amnesic Activity of a Novel Multimodal Derivative of Salicylamide, JJGW08, in Mice. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Elżbieta Żmudzka, Klaudia Lustyk, Kinga Sałaciak, Agata Siwek, Jolanta Jaśkowska, Marcin Kołaczkowski, Jacek Sapa, Karolina Pytka
Potential Anti-Amnesic Activity of a Novel Multimodal Derivative of Salicylamide, JJGW08, in Mice. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Elżbieta Żmudzka, Klaudia Lustyk, Monika Głuch-Lutwin, Małgorzata Wolak, Jolanta Jaśkowska, Marcin Kołaczkowski, Jacek Sapa, Karolina Pytka
Novel Multimodal Salicylamide Derivative with Antidepressant-like, Anxiolytic-like, Antipsychotic-like, and Anti-Amnesic Activity in Mice. Pharmaceuticals (Basel, Switzerland) 16 (2) (2023)
Elżbieta Żmudzka, Klaudia Lustyk, Agata Siwek, Małgorzata Wolak, Adam Gałuszka, Jolanta Jaśkowska, Marcin Kołaczkowski, Jacek Sapa, Karolina Pytka
Novel Arylpiperazine Derivatives of Salicylamide with α 1 -Adrenolytic Properties Showed Antiarrhythmic and Hypotensive Properties in Rats. International journal of molecular sciences 24 (1) (2022)
Klaudia Lustyk, Kinga Sałaciak, Agata Siwek, Barbara Filipek, Jacek Sapa, Henryk Marona, Dorota Żelaszczyk, Karolina Pytka
HBK-10, A Compound with α 1 -Adrenolytic Properties, Showed Antiarrhythmic and Hypotensive Effects in Rats. Pharmaceuticals (Basel, Switzerland) 15 (10) (2022)
Elżbieta Żmudzka, Klaudia Lustyk, Agata Siwek, Małgorzata Wolak, Adam Gałuszka, Jolanta Jaśkowska, Marcin Kołaczkowski, Jacek Sapa, Karolina Pytka
Novel Arylpiperazine Derivatives of Salicylamide with α 1 -Adrenolytic Properties Showed Antiarrhythmic and Hypotensive Properties in Rats. International journal of molecular sciences 24 (1) (2022)
Elżbieta Żmudzka, Klaudia Lustyk, Agata Siwek, Małgorzata Wolak, Adam Gałuszka, Jolanta Jaśkowska, Marcin Kołaczkowski, Jacek Sapa, Karolina Pytka
Novel Arylpiperazine Derivatives of Salicylamide with α 1 -Adrenolytic Properties Showed Antiarrhythmic and Hypotensive Properties in Rats. International journal of molecular sciences 24 (1) (2022)
Klaudia Lustyk, Kinga Sałaciak, Agata Siwek, Jacek Sapa, Paula Zaręba, Adam Gałuszka, Karolina Pytka
The Antiarrhythmic and Hypotensive Effects of S-61 and S-73, the Pyrrolidin-2-one Derivatives with α 1 -Adrenolytic Properties. International journal of molecular sciences 23 (18) (2022)
Elżbieta Żmudzka, Klaudia Lustyk, Monika Głuch-Lutwin, Barbara Mordyl, Alicja Zakrzewska-Sito, Paweł Mierzejewski, Jolanta Jaśkowska, Marcin Kołaczkowski, Jacek Sapa, Karolina Pytka
Antipsychotic- and Anxiolytic-like Properties of a Multimodal Compound JJGW08 in Rodents. International journal of molecular sciences 23 (24) (2022)
Elżbieta Żmudzka, Klaudia Lustyk, Monika Głuch-Lutwin, Barbara Mordyl, Alicja Zakrzewska-Sito, Paweł Mierzejewski, Jolanta Jaśkowska, Marcin Kołaczkowski, Jacek Sapa, Karolina Pytka
Antipsychotic- and Anxiolytic-like Properties of a Multimodal Compound JJGW08 in Rodents. International journal of molecular sciences 23 (24) (2022)
Elżbieta Żmudzka, Klaudia Lustyk, Agata Siwek, Małgorzata Wolak, Adam Gałuszka, Jolanta Jaśkowska, Marcin Kołaczkowski, Jacek Sapa, Karolina Pytka
Novel Arylpiperazine Derivatives of Salicylamide with α 1 -Adrenolytic Properties Showed Antiarrhythmic and Hypotensive Properties in Rats. International journal of molecular sciences 24 (1) (2022)
Elżbieta Żmudzka, Klaudia Lustyk, Monika Głuch-Lutwin, Barbara Mordyl, Alicja Zakrzewska-Sito, Paweł Mierzejewski, Jolanta Jaśkowska, Marcin Kołaczkowski, Jacek Sapa, Karolina Pytka
Antipsychotic- and Anxiolytic-like Properties of a Multimodal Compound JJGW08 in Rodents. International journal of molecular sciences 23 (24) (2022)
Elżbieta Żmudzka, Klaudia Lustyk, Monika Głuch-Lutwin, Barbara Mordyl, Alicja Zakrzewska-Sito, Paweł Mierzejewski, Jolanta Jaśkowska, Marcin Kołaczkowski, Jacek Sapa, Karolina Pytka
Antipsychotic- and Anxiolytic-like Properties of a Multimodal Compound JJGW08 in Rodents. International journal of molecular sciences 23 (24) (2022)
Kinga Sałaciak, Aleksandra Koszałka, Elżbieta Żmudzka, Karolina Pytka
The Calcium/Calmodulin-Dependent Kinases II and IV as Therapeutic Targets in Neurodegenerative and Neuropsychiatric Disorders. International journal of molecular sciences 22 (9) (2021)
Monika Głuch-Lutwin, Kinga Sałaciak, Alicja Gawalska, Marek Jamrozik, Joanna Sniecikowska, Adrian Newman-Tancredi, Marcin Kołaczkowski, Karolina Pytka
The selective 5-HT1A receptor biased agonists, F15599 and F13714, show antidepressant-like properties after a single administration in the mouse model of unpredictable chronic mild stress. Psychopharmacology 238 (8) (2021)
Kinga Sałaciak, Natalia Malikowska-Racia, Klaudia Lustyk, Agata Siwek, Monika Głuch-Lutwin, Grzegorz Kazek, Justyna Popiół, Jacek Sapa, Henryk Marona, Dorota Żelaszczyk, Karolina Pytka
Synthesis and Evaluation of the Antidepressant-like Properties of HBK-10, a Novel 2-Methoxyphenylpiperazine Derivative Targeting the 5-HT1A and D2 Receptors. Pharmaceuticals (Basel, Switzerland) 14 (8) (2021)
Klaudia Lustyk, Kinga Sałaciak, Paula Zaręba, Agata Siwek, Jacek Sapa, Karolina Pytka
The Antiarrhythmic Activity of Novel Pyrrolidin-2-one Derivative S-75 in Adrenaline-Induced Arrhythmia. Pharmaceuticals (Basel, Switzerland) 14 (11) (2021)
Kinga Sałaciak, Monika Głuch-Lutwin, Agata Siwek, Małgorzata Szafarz, Grzegorz Kazek, Marek Bednarski, Leszek Nowiński, Emma Mitchell, Magdalena Jastrzębska-Więsek, Anna Partyka, Anna Wesołowska, Marcin Kołaczkowski, Natalia Szkaradek, Henryk Marona, Jacek Sapa, Karolina Pytka
The antidepressant-like activity of chiral xanthone derivatives may be mediated by 5-HT1A receptor and β-arrestin signalling. Journal of psychopharmacology (Oxford, England) 34 (12) (2020)
Karolina Pytka, Monika Głuch-Lutwin, Magdalena Kotańska, Anna Waszkielewicz, Agnieszka Kij, Maria Walczak
Single Administration of HBK-15-a Triple 5-HT1A, 5-HT7, and 5-HT3 Receptor Antagonist-Reverses Depressive-Like Behaviors in Mouse Model of Depression Induced by Corticosterone. Molecular neurobiology 55 (5) (2017)
Karolina Pytka, Monika Głuch-Lutwin, Joanna Knutelska, Magdalena Jakubczyk, Anna Waszkielewicz, Magdalena Kotańska
HBK-14 and HBK-15 Do Not Influence Blood Pressure, Lipid Profile, Glucose Level, or Liver Enzymes Activity after Chronic Treatment in Rats. PloS one 11 (10) (2016)
Karolina Pytka, Katarzyna Gawlik, Dorota Pawlica-Gosiewska, Jadwiga Witalis, Anna Waszkielewicz
HBK-14 and HBK-15 with antidepressant-like and/or memory-enhancing properties increase serotonin levels in the hippocampus after chronic treatment in mice. Metabolic brain disease 32 (2) (2016)

Karolina Pytka.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Karolina Pytka